TrialJournal of cellular and molecular medicine2022

A randomized, placebo-controlled clinical trial of hydrogen/oxygen inhalation for non-alcoholic fatty liver disease.

Geru Tao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.